Covista Medical Schools Outperform U.S. Peers on USMLE Step 1 Pass Rates Across MCAT Bands
Event summary
- Covista's Ross and AUC medical schools matched or exceeded U.S. MD peers on USMLE Step 1 first-time pass rates across MCAT score ranges.
- Data analyzed from 2021–2023 matriculants showed RUSM and AUC students outperformed U.S. MD students in lower and middle MCAT bands.
- Covista attributes success to structured academic support programs and outcomes-focused curricula.
- RUSM and AUC reported 96% and 98% first-time residency attainment rates for 2025–2026 graduates, respectively.
The big picture
Covista's data challenges the traditional reliance on MCAT scores as the sole predictor of medical school success, highlighting the role of structured support and curricula. The findings come amid a critical healthcare workforce shortage, with nearly 702,000 healthcare jobs posted monthly in the U.S. Covista's model of cultivating rather than filtering students could reshape medical education and workforce development strategies.
What we're watching
- Scaling Success
- Whether Covista can sustain these outcomes as it expands its student base and broadens access to medical education.
- Workforce Impact
- The pace at which Covista's graduates contribute to addressing the U.S. healthcare workforce shortage.
- Regulatory Dynamics
- How regulatory bodies may respond to the performance data, particularly regarding accreditation and recognition of international medical graduates.